Dr. Vikas Le-kumar, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 146
Licensed in Alabama since 2025, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
AL license MD.51443 (first issued 2025; active) -
Internal Medicine Physician
MN license 69262
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Southeast Health Medical Center Dothan, AL
- Flowers Hospital Dothan, AL
- Medical Center Enterprise Enterprise, AL
- Medical Center Barbour Eufaula, AL
Medical groups
- Dothan Hematology and Oncology, P. C. (15 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 146
- Services billed
- 147
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 84 | 83 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 25 companies reported 50 payments worth $1,533 in total to this clinician.
| Incyte Corporation | $297 |
|---|---|
| Exelixis Inc. | $175 |
| Daiichi Sankyo Inc. | $154 |
| E.r. Squibb & Sons, L.l.c. | $137 |
| AstraZeneca Pharmaceuticals LP | $74.75 |
| Merck Sharp & Dohme LLC | $68.89 |
| Regeneron Healthcare Solutions, Inc. | $63.00 |
| Janssen Biotech, Inc. | $59.94 |
| Food and Beverage | $1,533 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.